KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Inventory: 2014-2025

Historic Inventory for Exact Sciences (EXAS) over the last 12 years, with Sep 2025 value amounting to $164.8 million.

  • Exact Sciences' Inventory rose 20.29% to $164.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $164.8 million, marking a year-over-year increase of 20.29%. This contributed to the annual value of $162.4 million for FY2024, which is 27.38% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Inventory is $164.8 million, which was down 3.92% from $171.5 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Inventory ranged from a high of $176.6 million in Q1 2025 and a low of $89.0 million during Q1 2021.
  • Moreover, its 3-year median value for Inventory was $132.8 million (2023), whereas its average is $143.9 million.
  • As far as peak fluctuations go, Exact Sciences' Inventory decreased by 2.60% in 2024, and later skyrocketed by 37.38% in 2025.
  • Over the past 5 years, Exact Sciences' Inventory (Quarterly) stood at $105.0 million in 2021, then increased by 12.63% to $118.3 million in 2022, then grew by 7.79% to $127.5 million in 2023, then rose by 27.38% to $162.4 million in 2024, then grew by 20.29% to $164.8 million in 2025.
  • Its last three reported values are $164.8 million in Q3 2025, $171.5 million for Q2 2025, and $176.6 million during Q1 2025.